Live Blog

MARKET WRAP: Sensex gains 160 pts; broader markets underperform, Infy up 7%

In the broader market, the S&P BSE MidCap settled 88 points, or 0.61 per cent, lower at 14,466 levels while the S&P BSE SmallCap closed 87 points, or 0.63 per cent, lower at 13,689 levels.

SI Reporter New Delhi
Stock market

3 min read Last Updated : Jul 15 2019 | 4:05 PM IST

3:43 PM

Sectoral trends on NSE at close

3:42 PM

Top gainers and losers on S&P BSE Sensex at close

3:42 PM

Market at close

3:41 PM

Market at close

3:39 PM

Closing Bell

The S&P BSE Sensex settled 160 points, or 0.41 per cent, higher at 38,897 while the broader Nifty50 too settled with gains of 36 points, or 0.36 per cent, at 11,588 levels. 
 

3:25 PM

RBL Bank dips over 5%

3:15 PM

CG Power dips over 8%

3:06 PM

Maruti trades over 1% higher

2:53 PM

Suzlon pins hopes on Brookfield deal for bond payback as investors wait

Investors in Indian corporate debt are watching whether a stressed wind-turbine maker will repay its dollar-denominated convertible bonds due on Tuesday, and help avoid further widening of strains in the nation’s credit market. Suzlon Energy Ltd., which became India’s biggest convertible note defaulter when it missed payments in 2012, must repay $172 million outstanding on such securities that were issued as part of a debt restructuring. READ MORE

2:46 PM

Stocks that hit 52-week high on S&P BSE Sensex

COMPANY PRICE(rs) 52 WK HIGH CHG(rs) CHG(%)
INFOSYS 775.30 777.20 48.20 6.63
INTELLECT DESIGN 283.00 292.00 2.00 0.71
SBI LIFE INSURAN 780.00 794.25 -0.60 -0.08
» More on 52 Week High

2:35 PM

Sun Pharma Advanced Research climbs over 15%

2:31 PM

NEWS ALERT | NCLT adjourns MCA's plea to bar IL&FS' auditors, to July 19: CNBC TV18

2:29 PM

Elara Capital on Infosys

Rating: ACCUMULATE
 
Target Price : Rs 790
 
Upside : 9%
 
CMP : Rs 727 (as on 12 July 2019)

After 1QFY19, we had been 170bp below Consensus on FY20E EBITDA margin as we had expected a YoY decline of 150bp to 22.5% with USD-INR assumption of 68.3. We had been optimistic about growth though, but now feel less confident that Infosys can continue double-digit growth organically. We lower revenue by 3.1% for FY20E and 2.9% for FY21E. We also lower EBITDA margin by 18bp for FY20E and 46bp for FY21E. We introduce FY22E and arrive at a new TP of INR 790 from INR 820 on 18x (unchanged) FY21E P/E. We reiterate Accumulate, but urge investors to switch to HCL Tech and Wipro as we see similar growth prospects and more reasonable valuation.​

2:23 PM

NEWS ALERT | NCLT adjourns MCA's plea to bar IL&FS' auditors: CNBC TV18

-- Next hearing on July 19

2:16 PM

Aurobindo Pharma slips over 3%

Topics :MARKET WRAP

First Published: Jul 15 2019 | 7:23 AM IST